Jump to content

Estradiol benzoate/estradiol valerate/hydroxyprogesterone caproate

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 2605:e000:1316:8b6c:9933:a899:486a:e36d (talk) at 23:04, 9 June 2019. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Estradiol benzoate /
estradiol valerate /
hydroxyprogesterone caproate
Combination of
Estradiol benzoateEstrogen
Estradiol valerateEstrogen
Hydroxyprogesterone caproateProgestogen
Clinical data
Trade namesSin-Ol
Other namesEB/EV/OHPC
Routes of
administration		Intramuscular injection

Estradiol benzoate/estradiol valerate/hydroxyprogesterone caproate (EB/EV/OHPC), sold under the brand name Sin-Ol, is a combination medication of estradiol benzoate (EB), an estrogen, estradiol valerate (EV), an estrogen, and hydroxyprogesterone caproate (OHPC), a progestin, which was reportedly used as a combined injectable contraceptive in women in the early 1970s.[1] It contained 1 mg EB, 10 mg EV, and 250 mg OHPC in oil solution, was provided in the form of 3 mL ampoules, and was administered by intramuscular injection at regular intervals.[1] The medication was manufactured by the pharmaceutical company Reuffer in Mexico.[1]

See also

References

  1. ^ a b c Harry W. Rudel; Fred A. Kinel (September 1972). "Oral Contraceptives. Human Fertility Studies and Side Effects". In M. Tausk (ed.). Pharmacology of the Endocrine System and Related Drugs: Progesterone, Progestational Drugs and Antifertility Agents. Vol. II. Pergamon Press. pp. 385–469. ISBN 978-0080168128. OCLC 278011135.



Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Estradiol_benzoate/estradiol_valerate/hydroxyprogesterone_caproate&oldid=901136651"